Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.

Item
http://www.wikidata.org/entity/Q33374797
Chemotherapy for advanced non-small cell lung cancer in the elderly populationPemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyPemetrexed in advanced non-small-cell lung cancer.A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (tTailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer.Pemetrexed for the treatment of non-small cell lung cancer.Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development.Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel.Utilizing radiolabeled 3'-deoxy-3'-[18F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
P2860

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.

Item
http://www.wikidata.org/entity/Q33374797
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@ast
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@en
type
label
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@ast
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@en
prefLabel
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@ast
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Single-agent pemetrexed or seq ...... r, randomized, phase II trial.
@en
P2093
P304
P31
P356
10.1097/JTO.0B013E318031CD62
P433
P478
P50
P577
P698
P921